Bradford Crutchfield - Dec 21, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Commercial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Dec 21, 2021
Transactions value $
$257,172
Form type
4
Date filed
12/23/2021, 03:26 PM
Previous filing
Dec 15, 2021
Next filing
Jan 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $5.63K +4.69K +10.89% $1.20 47.7K Dec 21, 2021 Direct
transaction TXG Class A Common Stock Options Exercise $252K +49.9K +104.54% $5.04 97.7K Dec 21, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -4.69K -100% $0.00* 0 Dec 21, 2021 Class A Common Stock 4.69K $1.20 Direct F1
transaction TXG Stock Option (right to buy) Options Exercise $0 -49.9K -44.7% $0.00 61.8K Dec 21, 2021 Class A Common Stock 49.9K $5.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.